Companies
We invest in companies that combine tech innovation and scientific insight to significantly improve patient-consumer engagement.
Personalized Care
Accessible technologies that improve individualized patient-consumer experiences—from advancements in care delivery, to preventative health education—which will unlock new opportunities for enhanced patient-consumer participation.
Ilant Health
Investment Stage: Seed
A value-based care platform to manage personalized obesity treatments while reducing total cost of care for employers and payers.
Handspring Health
Investment Stage: Series A
Pediatric mental health provider that integrates a digital platform, in-person clinics, and telehealth to deliver the right care, at the right time.
Biocanic
Investment Stage: Series A
A cloud-based SaaS platform to streamline, automate, and analyze all aspects of personalized integrative health programs, driving better efficiencies, scale, and outcomes for practitioners.
InsideTracker
Investment Stage: Series B
Personalized data and AI-driven analytics based on blood, DNA, and physiological markers to help people live healthier longer.
Consumer Bioactives
Novel foods, ingredients, nutraceuticals, and supplements that offer accessible, evidence-based solutions to address nutritional or metabolic deficiencies, empowering consumers to proactively sustain their health and well-being.
Novos
Investment Stage: Seed
A DTC longevity platform combining epigenetic testing, bioactive supplements, and digital content to improve healthspan.
Zero Acre Farms
Investment Stage: Seed
A cleaner, all-purpose cooking oil with heart-healthy fats, neutral taste, high smoke point, and smaller environmental footprint.
Caffree
Investment Stage: Incubation
A novel decaffeination technology that delivers better health, full flavor, greater convenience, and sustainability.
Therapeutics
Emerging platforms and therapeutics with a long-term vision for pursuing preventative applications while addressing the urgent medical needs of today.
Archon Biosciences
Investment Stage: Series A
AI-generated protein structures that improve the delivery of antibody therapies targeting specific areas of the body.
Deciduous Therapeutics
Investment Stage: Seed +
Developing novel small molecule compounds to restore native immune activity for healthy senescent cell management, with preventative applications across a range of age-related diseases.
Biomeasurement Technologies
Innovations in biomarker measurement across a range of modalities—blood, saliva, interstitial fluid, visual, audio and more—that activate patient-consumer engagement by creating awareness of bodily systems and behaviors.
Medicine 3.0 Ecosystem
Ecosystem investments that build critical infrastructure, strengthening the innovation and connectivity needed to advance the field of Medicine 3.0 across research tools, clinical practice, and consumer engagement.
Tastewise
Investment Stage: Series B
GenAI-powered consumer data platform that tracks food trends and help brands innovate, market, and develop products based on evolving consumer preferences.
Stealth Project
Investment Stage: Series A
An AI-driven drug discovery platform founded on novel chemistry. Project currently in stealth.